Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 12/21/2012 2:40:20 PM : Underperform Start Price: $2.28 ACUR Score: -1.62

the "fools gold " of the biotechs

Featured Broker Partners


Advertisement